For instance, deletion of sirtuin-3 (SIRT3), one of the most studied member of the family Class III HDACs, promotes HFD-induced NAFLD, and sodium butyrate supplementation can reduce such liver damage (Chen et al., 2019). The gene discussed is SIRT3; the disease is metabolic dysfunction-associated steatotic liver disease.